NCT02321371View on ClinicalTrials.gov

Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 19, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Acute-On-Chronic Liver Failure

Interventions

DRUG

Lactulose + Rifaximin

Lactulose + addition of Rifaximin 400 mg 8th hourly through enteral route

DRUG

Lactulose

Continuation of Lactulose therapy for further 48 hours.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02321371 - Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy. | Biotech Hunter | Biotech Hunter